Your browser doesn't support javascript.
loading
The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
Hillion, Joelle; Roy, Sujayita; Heydarian, Mohammad; Cope, Leslie; Xian, Lingling; Koo, Michael; Luo, Li Z; Kellyn, Kathleen; Ronnett, Brigitte M; Huso, Tait; Armstrong, Deborah; Reddy, Karen; Huso, David L; Resar, L M S.
Afiliação
  • Hillion J; Hematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Roy S; Hematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Heydarian M; Department of Biologic Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Cope L; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Xian L; Hematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Koo M; Hematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Luo LZ; Hematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Kellyn K; Pathobiology Graduate Program, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Molecular and Comparative Pathobiology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Ronnett BM; Pathobiology Graduate Program, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Huso T; Hematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Armstrong D; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Reddy K; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Biologic Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Huso DL; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Molecular and Comparative Pathobiology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Resar LMS; Hematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, United St
Gynecol Oncol ; 141(3): 580-587, 2016 06.
Article em En | MEDLINE | ID: mdl-27001612
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Carcinossarcoma / Cistadenocarcinoma Seroso / Metaloproteinase 2 da Matriz / Proteína HMGA1a Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Carcinossarcoma / Cistadenocarcinoma Seroso / Metaloproteinase 2 da Matriz / Proteína HMGA1a Idioma: En Ano de publicação: 2016 Tipo de documento: Article